Similarly, in another in vivo model (renal tubulointerstitial fibrosis), TAM could reduce renal fibrosis by decreasing the expression of extracellular matrix proteins and tissue TGF-β [15]. The gene discussed is TGFB1; the disease is renal fibrosis.